ESR1 and cancer: In contrast, CD8+ CTLs infiltrate status had no significant associations with DFS (Log-rank test: P = 0.265, Fig. 3C) and OS (Log-rank test: P = 0.465, Fig. 3D) in ER positive cancers (n = 253, table 5).